Breast cancer care today is highly specialised. Modern treatment requires precise staging, biomarker-based planning, and a multidisciplinary approach—principles supported by international guidelines such as the NCCN, ASCO and ESMO. We ensure every patient receives this level of care in an easy-to-understand and compassionate manner.
At Star Cancer Care & Breast Clinic, we are committed to delivering comprehensive, evidence-based breast cancer care through a patient-centred approach. Led by experienced breast and surgical oncologists, we offer advanced diagnostics, personalised treatment strategies.

At Star Cancer Care & Breast Clinic, we provide world-class, guideline-based breast cancer diagnosis and treatment, led by experienced breast and surgical oncologists. Our mission is to deliver accurate diagnosis, personalised treatment plans, advanced surgical expertise, and complete survivorship support for every woman and man facing a breast concern.
Early and accurate diagnosis is the foundation of successful treatment.
A detailed physical examination to assess lumps, skin changes, nipple discharge, and lymph nodes.
(CBE is an integral step in breast cancer assessment.)
For patients with strong family history, early-onset cancer, or hereditary cancer suspicion.
We provide comprehensive care for every stage and subtype:
Early, non-invasive breast cancer requiring accurate planning.
Management includes:
We follow a personalised, guideline-driven approach:
IBC is an aggressive and rare cancer requiring multimodality treatment:
Our aim is life prolongation, symptom relief, and high-quality survival.
Treatments include:
Removal of tumour with preservation of breast shape, often followed by radiation.
Options include:
A minimally invasive technique to check cancer spread with less risk of lymphedema.
Done when lymph nodes are involved.
Combining cancer removal with cosmetic techniques for best aesthetic and oncologic results.
Tailored regimens based on stage and subtype.
For ER/PR-positive cancers (e.g., Tamoxifen, Aromatase Inhibitors).
For selected triple-negative breast cancers.
Used to shrink tumours, improve breast-conservation rates, and guide therapy response.
This is strongly recommended for IBC and certain invasive cancers.
We partner with leading radiation oncology centres for:
Assessment and early management strategies are based on NCCN-recommended baseline screening.
Services include:
A structured long-term plan including:
If we can help in any way, please don’t hesitate to set a time to meet or talk, or leave your details and we’ll get back to you.